Zenith Labs Chapter 11
Reorganization plan filing deadline extended 120 days from Sept. 1 to Dec. 30. Generics company noted at the Aug. 29 hearing in Newark Federal Court that a further extension may be required. Court also extended Zenith's right to use collateral, subject to the requirement that monthly interest payments be made to the five-bank consortium. Zenith filed for Chapter 11 on May 4.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.